血管手术后肌钙蛋白升高的监测与管理
单中心质量改进研究纳入201例血管手术患者,术后第1-3天监测肌钙蛋白,17%患者升高,其中76%无症状。肌钙蛋白升高者1年死亡率高于正常者(12% vs. 2.4%,P=0.03),常规监测可强化他汀治疗。
要点
- 血管手术后常规监测肌钙蛋白可发现多数无症状性升高。
- 肌钙蛋白升高与1年死亡率增加相关。
- 监测可促进他汀强化、抗血小板调整和戒烟咨询。
核心结论
- 常规术后肌钙蛋白监测可强化无症状肌钙蛋白升高患者的他汀治疗,但能否降低长期心血管事件尚需进一步研究。
研究设计与样本
- 单中心质量改进研究,纳入2016年1月至12月间接受颈动脉内膜剥脱术、主动脉腔内修复术、腹股沟下旁路术、腹主动脉瘤开放修复术、外周血管介入术和腹股沟上旁路术的患者201例。
主要发现
- 肌钙蛋白升高见于17%(34/201)的患者,其中8例(24%)有心脏症状,26例(76%)无症状。
- 肌钙蛋白≥1.0 ng/mL的无症状患者有11例(5.5%)。
- 76%的肌钙蛋白升高患者接受了药物治疗强化,包括高强度他汀(58%)、抗血小板治疗增加(18%)和戒烟咨询(66%)。
- 52%的肌钙蛋白升高患者接受了心脏科会诊,肌钙蛋白≥1 ng/mL者会诊可能性更高(100%)(P < 0.001)。
- 门诊负荷试验依从率为66%。
关键数值与推荐
- 肌钙蛋白I升高定义为>0.034 ng/mL,≥1.0 ng/mL者需住院心脏科会诊。
- 治疗算法包括单药或双联抗血小板、高强度他汀、戒烟咨询和门诊心脏科会诊及负荷试验。
临床怎么用
- 对指定血管手术患者术后第1-3天常规监测肌钙蛋白,无论有无心脏症状。
- 肌钙蛋白I>0.034 ng/mL即启动治疗算法强化药物治疗,≥1.0 ng/mL者请心脏科会诊。
局限性
- 单中心研究,样本量有限,可能影响结果的普遍性。
- 未评估该监测策略对长期心血管发病率与死亡率的直接影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Postopertive troponin elevation may occur without typical or atypical cardiac symptoms and is associated with an increased 30-day morbidity and mortality. The objective of the study was to implement a quality improvement initiative of postoperative troponin surveillance algorithm aimed at intensifying medical management after vascular surgery. METHODS: We conducted a single-center study of postoperative troponin surveillance after vascular surgery (n = 201) at a tertiary care, academic medical center from January to December 2016. Troponin surveillance was performed on postoperative days 1-3 after carotid endarterectomy, endovascular aortic repair, infrainguinal bypass, open abdominal aortic aneurysm repair, peripheral vascular intervention, and suprainguinal bypass, regardless of cardiac symptoms. Patients with troponin I elevation (>0.034 ng/mL) were managed with a treatment algorithm which included single or dual antiplatelet (AP) agent, high-intensity statin therapy, smoking cessation consultation, and outpatient cardiology consultation and stress testing. Patients with troponin elevation ≥1.0 ng/mL received inpatient cardiology consultation. We assessed adherence to the protocol for intensification of best medical therapy defined as high-dose statin therapy, increase in AP therapy, and smoking cessation consultation according to the established algorithm. RESULTS: Troponin elevation was recorded in 17% (34/201) of patients and was associated with cardiac symptoms in 8 patients (24%), while 26 (76%) patients had an asymptomatic abnormal troponin on postoperative surveillance. One patient was excluded due to death immediately after SUPRA, resulting in 200 patients. Troponin elevation ≥1.0 ng/mL occurred in 11 asymptomatic patients (5.5%). Any intensification of medical therapy was instituted in 76% of patients with elevated troponin and included high-intensity statin therapy (58%), increase in AP therapy (18%), and smoking cessation consultation (66%). Once an elevated troponin level was recognized, 52% of our patients received cardiology consultation with an increased likelihood (100%) in patients with troponin ≥1 ng/mL (P < 0.001). Adherence to outpatient stress testing was 66%. Intensification of medical therapy was not significantly different between patients with abnormal troponin values, >0.034-1.0 (n = 23) versus ≥1.0 ng/mL (n = 10); statin therapy (P = 1.0), AP (P = 0.34), and smoking cessation (P = 1.0). One-year mortality was higher in patients with postoperative troponin elevation than those with normal postoperative troponin levels (12% vs. 2.4%; P = 0.03). CONCLUSIONS: Routine postoperative troponin surveillance results in intensification of statin therapy in patients with asymptomatic troponin elevation. Further study is needed to determine if this approach reduces long-term cardiovascular morbidity and mortality.
引用
- Shukla M, Callas PW, Lahiri JA, et al. Surveillance and Management of Troponin Elevation after Vascular Surgery. Ann Vasc Surg. 2019. PMID: 31075460. doi:10.1016/j.avsg.2019.02.025
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。